Skip to content
lifestyle.side.cr
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Rznomics
Rznomics Granted Orphan Medicinal Product Designation for RZ-001 for the Treatment of Glioma by the European Commission
October 22, 2026
Rznomics Receives Positive Opinion for Orphan Medicinal Product Designation of RZ-001 for Glioma
September 30, 2026
Rznomics Reports Major Advances in High-Efficiency Circular RNA Production in Nucleic Acids Research
September 7, 2026
Rznomics Joins Lilly Gateway Labs in San Diego to Accelerate RNA Therapeutics
August 23, 2026